Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "neurexin pseudogene" (ENSG00000235617) represents a non-functional genomic sequence similar to the neurexin gene family but does not encode a functional protein product. Unlike active neurexin genes (such as NRXN1, NRXN2, or NRXN3), this pseudogene does not participate in biological processes, serve as a therapeutic target, or play a role in disease mechanisms. It is annotated in genomic databases for completeness but is not relevant to drug discovery or therapeutic intervention. The search results and gene databases do not identify ENSG00000235617 as encoding an active, functional neurexin molecule involved in human disease or therapeutic modulation. The well-known neurexin targets (e.g., Neurexin 1, encoded by NRXN1) are distinct from pseudogenes and have major roles in synaptic function and neuropsychiatric disorders, but these properties do NOT apply to this pseudogene entry. ENSG00000235617 (neurexin pseudogene) is a non-coding, non-functional genomic sequence, not a valid drug target or functional molecule. If you are seeking information on the functional neurexin family (such as "Neurexin-1" or NRXN1), those should be referenced by their canonical gene/protein entries, not by this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurexin pseudogene.